Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Colucci

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
Journal of Clinical Microbiology|January 19, 2007
COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasmaTiziano Allice, Francesco Cerutti, Fabrizia Pittaluga, et al.
Expert Opinion on Biological Therapy|April 17, 2009
KRAS mutations and sensitivity to anti-EGFR monoclonal antibodies in metastatic colorectal carcinoma: an open issueNicola Silvestris, Stefania Tommasi, Daniele Santini, et al.
Clinical Colorectal Cancer|December 17, 2002
Combination of 5-fluorouracil and irinotecan on modulation of thymidylate synthase and topoisomerase I expression and cell cycle regulation in human colon cancer LoVo cells: clinical relevanceJian-Ming Xu, Amalia Azzariti, Stefania Tommasi, et al.
Thrombosis and Haemostasis|June 10, 2011
Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep-vein thrombosis in an antithrombin deficient patient: another case of factor IX propeptide mutationMaximilian Jahns, Dorothea Friess, Franziska Demarmels Biasiutti, et al.
Journal of Medical Virology|December 22, 2007
Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assayFabrizia Pittaluga, Tiziano Allice, Maria Lorena Abate, et al.
American Journal of Clinical Oncology|December 1, 2005
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106)Francesco Giuliani, Stefano Molica, Evaristo Maiello, et al.
Clinics and Research in Hepatology and Gastroenterology|December 19, 2021
Italian migrants study: An HCV and HBV micro-elimination pilot projectGiuseppe Colucci, Sara Uceda Renteria, Giovanna Lunghi, et al.
International Journal of Cancer|June 16, 2004
Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patientsAngelo Paradiso, JanMing Xu, Anita Mangia, et al.
Cancer|March 29, 2002
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia MeridionaleGiuseppe Colucci, Francesco Giuliani, Vittorio Gebbia, et al.
Oncology|February 5, 2010
The dark side of the moon: the PI3K/PTEN/AKT pathway in colorectal carcinomaNicola Silvestris, Stefania Tommasi, Daniela Petriella, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
Journal of Clinical Microbiology|January 19, 2007
COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasmaTiziano Allice, Francesco Cerutti, Fabrizia Pittaluga, et al.
Expert Opinion on Biological Therapy|April 17, 2009
KRAS mutations and sensitivity to anti-EGFR monoclonal antibodies in metastatic colorectal carcinoma: an open issueNicola Silvestris, Stefania Tommasi, Daniele Santini, et al.
Clinical Colorectal Cancer|December 17, 2002
Combination of 5-fluorouracil and irinotecan on modulation of thymidylate synthase and topoisomerase I expression and cell cycle regulation in human colon cancer LoVo cells: clinical relevanceJian-Ming Xu, Amalia Azzariti, Stefania Tommasi, et al.
Thrombosis and Haemostasis|June 10, 2011
Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep-vein thrombosis in an antithrombin deficient patient: another case of factor IX propeptide mutationMaximilian Jahns, Dorothea Friess, Franziska Demarmels Biasiutti, et al.
Journal of Medical Virology|December 22, 2007
Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assayFabrizia Pittaluga, Tiziano Allice, Maria Lorena Abate, et al.
American Journal of Clinical Oncology|December 1, 2005
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106)Francesco Giuliani, Stefano Molica, Evaristo Maiello, et al.
Clinics and Research in Hepatology and Gastroenterology|December 19, 2021
Italian migrants study: An HCV and HBV micro-elimination pilot projectGiuseppe Colucci, Sara Uceda Renteria, Giovanna Lunghi, et al.
International Journal of Cancer|June 16, 2004
Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patientsAngelo Paradiso, JanMing Xu, Anita Mangia, et al.
Cancer|March 29, 2002
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia MeridionaleGiuseppe Colucci, Francesco Giuliani, Vittorio Gebbia, et al.
Oncology|February 5, 2010
The dark side of the moon: the PI3K/PTEN/AKT pathway in colorectal carcinomaNicola Silvestris, Stefania Tommasi, Daniela Petriella, et al.
Pageof 14